Home > Insider Trading > Filing (0001736297-24-000067)

Filing Details

Accession Number:: 0001736297-24-000067
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-12-06 16:31:30
Reporting Period:: 2024-12-04

Accepted Time:: 2024-12-06 16:31:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1736297	Astera Labs Inc.	ALAB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1399546	Truett Michael Tate	C/O Astera Labs, Inc. 2901 Tasman Drive, Suite 205 Santa Clara CA 95054	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-12-04	3,622	$115.44	1,425,266	No	4	S	Indirect	By Tate Trust
Common Stock	Disposition	2024-12-04	1,900	$116.66	1,423,366	No	4	S	Indirect	By Tate Trust
Common Stock	Disposition	2024-12-04	2,840	$117.68	1,420,526	No	4	S	Indirect	By Tate Trust
Common Stock	Disposition	2024-12-04	2,602	$118.44	1,417,924	No	4	S	Indirect	By Tate Trust
Common Stock	Disposition	2024-12-04	4,353	$119.67	1,413,571	No	4	S	Indirect	By Tate Trust
Common Stock	Disposition	2024-12-04	683	$120.58	1,412,888	No	4	S	Indirect	By Tate Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Tate Trust
No	4	S	Indirect	By Tate Trust
No	4	S	Indirect	By Tate Trust
No	4	S	Indirect	By Tate Trust
No	4	S	Indirect	By Tate Trust
No	4	S	Indirect	By Tate Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	286,424	Direct

Footnotes

The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.0900 to $116.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.0900 to $117.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.1400 to $118.1100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.1500 to $119.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.1800 to $120.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.1800 to $121.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.